These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1065 related articles for article (PubMed ID: 1329982)
21. Studies on adrenal phenylethanolamine N- methyltransferase (PNMT) with S K & F 64139, a selective inhibitor. Pendleton RG; Kaiser C; Gessner G J Pharmacol Exp Ther; 1976 Jun; 197(3):623-32. PubMed ID: 6786 [TBL] [Abstract][Full Text] [Related]
22. Attenuated aortic vasodilation and sympathetic prejunctional facilitation in epinephrine-deficient mice: selective impairment of β2-adrenoceptor responses. Moreira-Rodrigues M; Graça AL; Ferreira M; Afonso J; Serrão P; Morato M; Ferreirinha F; Correia-de-Sá P; Ebert SN; Moura D J Pharmacol Exp Ther; 2014 Nov; 351(2):243-9. PubMed ID: 25161169 [TBL] [Abstract][Full Text] [Related]
23. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Lincoln DT; Ali Emadi EM; Tonissen KF; Clarke FM Anticancer Res; 2003; 23(3B):2425-33. PubMed ID: 12894524 [TBL] [Abstract][Full Text] [Related]
24. Assessment of the functional role of brain adrenergic neurons: chronic effects of phenylethanolamine N-methyltransferase inhibitors and alpha adrenergic receptor antagonists on brain norepinephrine metabolism. Stolk JM; Vantini G; Perry BD; Guchhait RB; U'Prichard DC J Pharmacol Exp Ther; 1984 Sep; 230(3):577-86. PubMed ID: 6147403 [TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid induction of epinephrine synthesizing enzyme in rat skeletal muscle and insulin resistance. Kennedy B; Elayan H; Ziegler MG J Clin Invest; 1993 Jul; 92(1):303-7. PubMed ID: 8325998 [TBL] [Abstract][Full Text] [Related]
26. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice. de Vries TJ; Kitson JL; Silvers WK; Mintz B Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649 [TBL] [Abstract][Full Text] [Related]
27. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. Isiklar I; Leeds NE; Fuller GN; Kumar AJ AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597 [TBL] [Abstract][Full Text] [Related]
28. Studies on SK&F 29661, an organ-specific inhibitor of phenylethanolamine N-methyltransferase. Pendleton RG; Gessner G; Weiner G; Jenkins B; Sawyer J; Bondinell W; Intoccia A J Pharmacol Exp Ther; 1979 Jan; 208(1):24-30. PubMed ID: 215747 [TBL] [Abstract][Full Text] [Related]
29. bcl-2 protein expression in melanocytic neoplasms of the skin. Ramsay JA; From L; Kahn HJ Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475 [TBL] [Abstract][Full Text] [Related]
30. Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Gerlini G; Tun-Kyi A; Dudli C; Burg G; Pimpinelli N; Nestle FO Am J Pathol; 2004 Dec; 165(6):1853-63. PubMed ID: 15579430 [TBL] [Abstract][Full Text] [Related]
31. Phenylethanolamine N-methyltransferase-like immunoreactivity in psoriasis. An immunohistochemical study on catecholamine synthesizing enzymes and neuropeptides of the skin. Johansson O; Olsson A; Enhamre A; Hammar H; Goldstein M Acta Derm Venereol; 1987; 67(1):1-7. PubMed ID: 2436407 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549 [TBL] [Abstract][Full Text] [Related]
33. Quinones are reduced by 6-tetrahydrobiopterin in human keratinocytes, melanocytes, and melanoma cells. Schallreuter KU; Rokos H; Chavan B; Gillbro JM; Cemeli E; Zothner C; Anderson D; Wood JM Free Radic Biol Med; 2008 Feb; 44(4):538-46. PubMed ID: 17997383 [TBL] [Abstract][Full Text] [Related]
34. The effect of epinephrine on phenylethanolamine N-methyltransferase in cultured explants of adrenal medulla. Burke WJ; Davis JW; Joh TH; Reis DJ; Horenstein S; Bhagat BD Endocrinology; 1978 Aug; 103(2):358-67. PubMed ID: 744091 [TBL] [Abstract][Full Text] [Related]
35. Diversified β-2-adrenergic Receptor Expression and Action in Melanoma Cells. Janik ME; Szlęzak D; Surman M; Gołas A; Lityńska A; Przybyło M Anticancer Res; 2017 Jun; 37(6):3025-3033. PubMed ID: 28551641 [TBL] [Abstract][Full Text] [Related]
36. Hypertension and a tumor of the glomus jugulare region. Evidence for epinephrine biosynthesis. Blumenfeld J; Cohen N; Anwar M; Teitelman G; Laragh JH; Ruggiero DA Am J Hypertens; 1993 May; 6(5 Pt 1):382-7. PubMed ID: 8099794 [TBL] [Abstract][Full Text] [Related]
37. Studies on SK and F 7698; an inhibitor of phenylethanolamine N-methyltransferase (PNMT). Pendleton RG; Kaiser C; Gessner G; Finlay E; Green H J Pharmacol Exp Ther; 1974 Sep; 190(3):551-62. PubMed ID: 4415962 [No Abstract] [Full Text] [Related]
39. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001 [TBL] [Abstract][Full Text] [Related]
40. Genetic alteration of catecholamine specificity in transgenic mice. Kobayashi K; Sasaoka T; Morita S; Nagatsu I; Iguchi A; Kurosawa Y; Fujita K; Nomura T; Kimura M; Katsuki M Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1631-5. PubMed ID: 1542654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]